PRMT1 potentiates chondrosarcoma development through activation of YAP activity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PRMT1 potentiates chondrosarcoma development through activation of YAP activity
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-03
DOI
10.1002/mc.23108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway
- (2018) Xiu-Ping Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Biological aspects of chondrosarcoma: Leaps and hurdles
- (2018) Benoîte Mery et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells
- (2018) Youli Zhang et al. EXPERIMENTAL CELL RESEARCH
- Targeting IRF3 as a YAP agonist therapy against gastric cancer
- (2018) Shi Jiao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling
- (2018) Changbao Chen et al. CANCER GENE THERAPY
- Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
- (2018) Elahe Nazeri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A comprehensive evaluation of Hippo pathway silencing in sarcomas
- (2018) Nicole M. Merritt et al. Oncotarget
- Novel therapeutic approaches in chondrosarcoma
- (2017) Genovefa Polychronidou et al. Future Oncology
- Arginine Methylation: The Coming of Age
- (2017) Roméo S. Blanc et al. MOLECULAR CELL
- Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
- (2016) Ngai Cheung et al. CANCER CELL
- Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells
- (2016) Sara C. Larsen et al. Science Signaling
- TAZ and YAP are frequently activated oncoproteins in sarcomas
- (2016) Colleen A. Fullenkamp et al. Oncotarget
- Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells
- (2016) Sara C. Larsen et al. Science Signaling
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition
- (2015) M. Kim et al. EMBO REPORTS
- The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications
- (2015) Marcello Maugeri-Saccà et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
- (2015) Bolag Altan et al. Gastric Cancer
- Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
- (2014) K.-W. Lee et al. CLINICAL CANCER RESEARCH
- Sensing the local environment: actin architecture and Hippo signalling
- (2014) Pedro Gaspar et al. CURRENT OPINION IN CELL BIOLOGY
- The Hippo signaling pathway in stem cell biology and cancer
- (2014) J.-S. Mo et al. EMBO REPORTS
- Elevated Levels of Dickkopf-1 Are Associated with β-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma
- (2014) Changbao Chen et al. PLoS One
- CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features
- (2013) Rania Elakoum et al. BIOCHIMIE
- Protein arginine methylation of non-histone proteins and its role in diseases
- (2013) Han Wei et al. CELL CYCLE
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
- (2013) Randy Johnson et al. NATURE REVIEWS DRUG DISCOVERY
- The role of protein arginine-methyltransferase 1 in gliomagenesis
- (2012) Shan Wang et al. BMB Reports
- The Hippo Pathway
- (2012) K. F. Harvey et al. Cold Spring Harbor Perspectives in Biology
- Association of Elevated HIF-2α Levels with Low Beclin 1 Expression and Poor Prognosis in Patients with Chondrosarcoma
- (2011) Changbao Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Arginine methylation-dependent regulation of ASK1 signaling by PRMT1
- (2011) J-H Cho et al. CELL DEATH AND DIFFERENTIATION
- Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling
- (2011) B Cha et al. ONCOGENE
- Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt
- (2011) J.-i. Sakamaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- YAP is a candidate oncogene for esophageal squamous cell carcinoma
- (2010) Tomoki Muramatsu et al. CARCINOGENESIS
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
- (2010) Masanori Yoshimatsu et al. INTERNATIONAL JOURNAL OF CANCER
- Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma
- (2010) Changbao Chen et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- (2009) Michelle Z. Xu et al. CANCER
- A Mouse PRMT1 Null Allele Defines an Essential Role for Arginine Methylation in Genome Maintenance and Cell Proliferation
- (2009) Z. Yu et al. MOLECULAR AND CELLULAR BIOLOGY
- Arginine Methylation of FOXO Transcription Factors Inhibits Their Phosphorylation by Akt
- (2008) Kazuyuki Yamagata et al. MOLECULAR CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started